• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE INTEGRITY RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE INTEGRITY RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Arrhythmia (1721); Myocardial Infarction (1969); Thrombosis (2100); Heart Failure (2206); Injury (2348); Vascular Dissection (3160)
Event Date 05/14/2019
Event Type  Injury  
Manufacturer Narrative
Journal title: comparison between the outcomes of using biodegradable-polymer drug-eluting stents and those using durable-polymer drug-eluting stents in acute coronary syndrome patients undergoing percutaneous coronary intervention.Date of event = date of publication.Doi.Org/10.3889/oamjms.2019.345.If information is provided in the future, a supplemental report will be issued.
 
Event Description
205 patients were enrolled in a study.The aim of the study was to compare the biodegradable-polymer des with durable polymer des when it comes to reducing the incidence of non-st elevation acute coronary syndrome (nsteacs) associated with adverse events.A selection of patients received resolute integrity rx drug eluting stents as part of the study.Patients were noted to have coronary lesions narrowed by 60%.Adverse events / procedural complications reported included acute in-stent thrombosis, arrhythmia, no-reflow phenomenon and coronary dissection.Revascularization (tlr), mi, lv dysfunction and mortality were reported in hospital.A selection of patients that received durable-polymer des (including resolute integrity) consented to have repeat coronary angiography within 1 year.Angina pains were reported with a small number of patients requiring tlr and experiencing mi.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE INTEGRITY RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key9289407
MDR Text Key165378230
Report Number9612164-2019-04677
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeEG
PMA/PMN Number
P110013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 11/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/07/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/15/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age57 YR
-
-